| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 644043 | Null | 0.0100995289754787 | 0.51641161 |
| NSC 663334 | Null | 0.0100995289754787 | 0.35222377 |
| NSC 671170 | Null | 0.0100995289754787 | 0.12778905 |
| NSC 671392 | Null | 0.0100995289754787 | 0.23073396 |
| NSC 676779 | Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop | 0.0100995289754787 | -0.17059714 |
| NSC 681239 | Bortezomib | 0.0100995289754787 | -0.084999498 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.0100995289754787 | 0.33038179 |
| NSC 695941 | 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate | 0.0100995289754788 | 0.63901061 |
| NSC 696257 | 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A | 0.0100995289754788 | -0.046141872 |
| NSC 703092 | Null | 0.0100995289754788 | 0.34292392 |